OR WAIT null SECS
Samuel Powell is a scientist, analytical research and development, pharmatherapeutics pharmaceutical sciences, Pfizer, Inc.
March 02, 2015
Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.